Leptin and Ghrelin Dynamics: Unraveling Their Influence on Food Intake, Energy Balance, and the Pathophysiology of Type 2 Diabetes Mellitus

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2024 Jun 27

PMID 38932792

Authors

Uma Vijayashankar

Rajalakshmi Ramashetty

Mahesh Rajeshekara

Nagashree Vishwanath

Anshu Kumar Yadav

Akila Prashant

Rajeshwari Lokeshwaraiah

Affiliations

Soon will be listed here.

Abstract

Purpose: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and impaired glucose homeostasis. In recent years, there has been growing interest in the role of hunger and satiety hormones such as ghrelin and leptin in the development and progression of T2DM. In this context, the present literature review aims to provide a comprehensive overview of the current understanding of how ghrelin and leptin influences food intake and maintain energy balance and its implications in the pathophysiology of T2DM.

Methods: A thorough literature search was performed using PubMed and Google Scholar to choose the studies that associated leptin and ghrelin with T2DM. Original articles and reviews were included, letters to editors and case reports were excluded.

Results: This narrative review article provides a comprehensive summary on mechanism of action of leptin and ghrelin, its association with obesity and T2DM, how they regulate energy and glucose homeostasis and potential therapeutic implications of leptin and ghrelin in managing T2DM.

Conclusion: Ghrelin, known for its appetite-stimulating effects, and leptin, a hormone involved in the regulation of energy balance, have been implicated in insulin resistance and glucose metabolism. Understanding the complexities of ghrelin and leptin interactions in the context of T2DM may offer insights into novel therapeutic strategies for this prevalent metabolic disorder. Further research is warranted to elucidate the molecular mechanisms underlying these hormone actions and to explore their clinical implications for T2DM prevention and management.

Citing Articles

Beyond weight loss: exploring the neurological ramifications of altered gut microbiota post-bariatric surgery.

Almheiri R, Hajjar B, Alkhaaldi S, Rabeh N, Aljoudi S, Abd-Elrahman K J Transl Med. 2025; 23(1):223.

PMID: 39994634 PMC: 11852891. DOI: 10.1186/s12967-025-06201-2.

PI3K/AKT signaling and neuroprotection in ischemic stroke: molecular mechanisms and therapeutic perspectives.

Liu T, Li X, Zhou X, Chen W, Wen A, Liu M Neural Regen Res. 2024; 20(10):2758-2775.

PMID: 39435629 PMC: 11826468. DOI: 10.4103/NRR.NRR-D-24-00568.

References

Robertson S, Leinninger G, Myers Jr M . Molecular and neural mediators of leptin action. Physiol Behav. 2008; 94(5):637-42. PMC: 2516921. DOI: 10.1016/j.physbeh.2008.04.005. View

Banks W, Coon A, Robinson S, Moinuddin A, Shultz J, Nakaoke R . Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004; 53(5):1253-60. DOI: 10.2337/diabetes.53.5.1253. View

Perello M, Cornejo M, De Francesco P, Fernandez G, Gautron L, Valdivia L . The controversial role of the vagus nerve in mediating ghrelin's actions: gut feelings and beyond. IBRO Neurosci Rep. 2022; 12:228-239. PMC: 9210457. DOI: 10.1016/j.ibneur.2022.03.003. View

Haring S, Harris R . The relation between dietary fructose, dietary fat and leptin responsiveness in rats. Physiol Behav. 2011; 104(5):914-22. PMC: 3183414. DOI: 10.1016/j.physbeh.2011.05.032. View

Hsuchou H, Kastin A, Mishra P, Pan W . C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation. Cell Physiol Biochem. 2012; 30(5):1109-19. PMC: 4099000. DOI: 10.1159/000343302. View

Gahete M, Rincon-Fernandez D, Villa-Osaba A, Hormaechea-Agulla D, Ibanez-Costa A, Martinez-Fuentes A . Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight. J Endocrinol. 2013; 220(1):R1-24. DOI: 10.1530/JOE-13-0391. View

Gruzman A, Babai G, Sasson S . Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations. Rev Diabet Stud. 2009; 6(1):13-36. PMC: 2712919. DOI: 10.1900/RDS.2009.6.13. View

Pico C, Palou M . Leptin and Metabolic Programming. Nutrients. 2022; 14(1). PMC: 8746998. DOI: 10.3390/nu14010114. View

Perez-Perez A, Sanchez-Jimenez F, Vilarino-Garcia T, Sanchez-Margalet V . Role of Leptin in Inflammation and Vice Versa. Int J Mol Sci. 2020; 21(16). PMC: 7460646. DOI: 10.3390/ijms21165887. View

10.

Nogueiras R, Perez-Tilve D, Wortley K, Tschop M . Growth hormone secretagogue (ghrelin-) receptors--a complex drug target for the regulation of body weight. CNS Neurol Disord Drug Targets. 2006; 5(3):335-43. DOI: 10.2174/187152706777452227. View

11.

Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R . Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol (Lausanne). 2023; 14:1161521. PMC: 10161731. DOI: 10.3389/fendo.2023.1161521. View

12.

Halaas J, Boozer C, Blair-West J, Fidahusein N, Denton D, Friedman J . Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A. 1997; 94(16):8878-83. PMC: 23177. DOI: 10.1073/pnas.94.16.8878. View

13.

Hornsby A, Redhead Y, Rees D, Ratcliff M, Reichenbach A, Wells T . Short-term calorie restriction enhances adult hippocampal neurogenesis and remote fear memory in a Ghsr-dependent manner. Psychoneuroendocrinology. 2015; 63:198-207. PMC: 4686051. DOI: 10.1016/j.psyneuen.2015.09.023. View

14.

Morrison C . Leptin resistance and the response to positive energy balance. Physiol Behav. 2008; 94(5):660-3. PMC: 2517010. DOI: 10.1016/j.physbeh.2008.04.009. View

15.

Dalvi P, Nazarians-Armavil A, Purser M, Belsham D . Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro. Endocrinology. 2012; 153(5):2208-22. DOI: 10.1210/en.2011-1795. View

16.

Delhanty P, Lely A . Ghrelin and glucose homeostasis. Peptides. 2011; 32(11):2309-18. DOI: 10.1016/j.peptides.2011.03.001. View

17.

Howick K, Griffin B, Cryan J, Schellekens H . From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation. Int J Mol Sci. 2017; 18(2). PMC: 5343809. DOI: 10.3390/ijms18020273. View

18.

Barb C, Hausman G, Lents C . Energy metabolism and leptin: effects on neuroendocrine regulation of reproduction in the gilt and sow. Reprod Domest Anim. 2008; 43 Suppl 2:324-30. DOI: 10.1111/j.1439-0531.2008.01173.x. View

19.

Walker A, Rivera P, Wang Q, Chuang J, Tran S, Osborne-Lawrence S . The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis. Mol Psychiatry. 2014; 20(4):500-8. PMC: 4206684. DOI: 10.1038/mp.2014.34. View

20.

Ogurtsova K, Guariguata L, Barengo N, Ruiz P, Sacre J, Karuranga S . IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2021; 183:109118. DOI: 10.1016/j.diabres.2021.109118. View